Status:
UNKNOWN
Persistent Dyspnea in Post COVID_19 and Pulmonary Function
Lead Sponsor:
Assiut University
Conditions:
covid_19 Patients
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 has a high spread rate, millions of people have been infected around the world. Patients complained of different symptoms as fever, dry cough and fatigue which is mild in about 80% of cases, ...
Detailed Description
COVID-19 has a high spread rate, millions of people have been infected around the world. Patients complained of different symptoms as fever, dry cough and fatigue which is mild in about 80% of cases, ...
Eligibility Criteria
Inclusion
- Confirmed or clinically and radiologically highly suspected Covid19-infection
- Symptom duration at least 12 weeks following first occurrence of symptoms
- Patients with dyspnea score 2, 3 and 4 on mMRC
- No other disease that better could explain the symptoms (dyspnea) than Covid-19
Exclusion
- Age \<18
- pregnant women
- terminally ill patients
- active covid-19 infection
- previous known severe pulmonary or heart disease
- inability to perform pulmonary function or cardiopulmonary exercise tests.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05228678
Start Date
April 1 2022
End Date
April 1 2024
Last Update
February 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.